4 years of revenue, earnings, cash-flow and balance-sheet history from public filings.
Sarepta Therapeutics, Inc. (SRPT) operates in the Biotechnology industry and is headquartered in Cambridge, United States with about 835 employees. Its market capitalization is roughly $2 billion. In the fiscal year ended 2025-12-31, SRPT reported $2.2B in revenue and ($713M) in net income.
Sarepta Therapeutics, Inc., a commercial-stage biopharmaceutical company, focuses on the discovery and development of RNA-targeted therapeutics, siRNA platform, gene therapy, and other genetic therapeutic modalities for the treatment of rare diseases.
Interactive charts & full statements → Open the SRPT valuation workbench →
| Income statement | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|---|
| Total Revenue | $2.2B | $1.9B | $1.2B | $933M | — |
| Gross Profit | $1.4B | $1.6B | $1.1B | $793M | — |
| Operating Income (EBIT) | ($658M) | $218M | ($268M) | ($536M) | — |
| Net Income | ($713M) | $235M | ($536M) | ($704M) | — |
USD; $M / $B as marked. Newest period first. Source: public company filings (via Yahoo Finance aggregation).
| Quarterly income statement | 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 | 2025-03-31 | 2024-12-31 |
|---|---|---|---|---|---|---|
| Total Revenue | $731M | $443M | $399M | $611M | $745M | — |
| Gross Profit | $622M | $44M | $249M | $458M | $607M | — |
| Operating Income (EBIT) | $358M | ($410M) | ($63M) | $116M | ($300M) | — |
| Net Income | $331M | ($283M) | ($180M) | $197M | ($448M) | — |
USD; $M / $B as marked. Newest period first. Source: public company filings (via Yahoo Finance aggregation).
| Balance sheet | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|---|
| Total Assets | $3.3B | $4.0B | $3.3B | $3.1B | — |
| Total Liabilities | $2.2B | $2.4B | $2.4B | $2.7B | — |
USD; $M / $B as marked. Newest period first. Source: public company filings (via Yahoo Finance aggregation).
Quarterly statements, profitability ratios, price history, insider activity and institutional holders are in the interactive SRPT viewer.
About TickerBase · Data methodology & sources